IDEAYA Biosciences Inc. (IDYA)

IDYA trades at $27.64, 22.8% above the near-term max pain of $22.5 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($22.5-$25), signaling increased put positioning or downside protection. Key magnetic zone at 23 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for IDYA shows a downward trend from 25 to 22.5, indicating bearish sentiment or hedging activity. The 11% spread signals divergent expectations across timeframes. Most levels below 27.64 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.